Literature DB >> 33985708

Intimate Partner Violence in the LGBTQ+ Community: Experiences, Outcomes, and Implications for Primary Care.

Autumn M Bermea1, Danielle C Slakoff2, Abbie E Goldberg3.   

Abstract

Lesbian, gay, bisexual, transgender, queer, and other sexual and gender (LGBTQ+) minorities experience intimate partner violence (IPV) at higher rates than heterosexual and/or cisgender people. Providers often are less prepared to work with LGBTQ+ survivors, which can be the result of a reliance on stereotypes on what constitutes an IPV victim. This article provides recommendations for working with LGBTQ+ survivors, including screening for IPV regardless of sexual orientation or gender identity, participating in LGBTQ+-affirming trainings regarding IPV, and creating a welcoming and inclusive space that promotes LGBTQ+ survivors' comfort in disclosing IPV.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abuse; Domestic violence; Gender minority; LGBT; Sexual minority; Transgender

Year:  2021        PMID: 33985708     DOI: 10.1016/j.pop.2021.02.006

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  3 in total

1.  Online Conversations About Abuse: Responses to IPV Survivors from Support Communities.

Authors:  Jason B Whiting; Bria Nicole Davies; Brady C Eisert; Alyssa Banford Witting; Shayne R Anderson
Journal:  J Fam Violence       Date:  2022-07-22

2.  Recovering from Intimate Partner Violence through Strengths and Empowerment (RISE): Initial Evaluation of the Clinical Effects of RISE Administered in Routine Care in the US Veterans Health Administration.

Authors:  Katherine M Iverson; Sara B Danitz; Stephanie K Low; Jennifer A Knetig; Kathryn W Doyle; LeAnn E Bruce
Journal:  Int J Environ Res Public Health       Date:  2022-07-20       Impact factor: 4.614

Review 3.  Update on Domestic Violence and Traumatic Brain Injury: A Narrative Review.

Authors:  Kellianne Costello; Brian D Greenwald
Journal:  Brain Sci       Date:  2022-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.